ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Diabetes Significantly Impacts Quality of Life Following Kidney Transplant

    C. Musgrave, N. Pilch, H. Meadows, J. McGillicuddy, C. Bratton, K. Chavin, P. Baliga, D. Taber

    Dept of Pharmacy Services, MUSC, Charleston, SC; Dept of Transplant Surgery, MUSC, Charleston, SC

    Purpose: Kidney transplant (KTx) has the potential to substantially improve quality of life (QOL) through improvements in performance status and life expectancy. Few studies have…
  • 2013 American Transplant Congress

    North American Results from the Multicenter Randomized Trial of Everolimus vs Mycophenolate Mofetil in Heart Transplantation

    J. Kobashigawa, D. Pauly, H. Ross, A. Kfoury, A. Van Bakel, D. Patel, A. Wiland, P. Lopez, A. Balfour, R. Starling, H. Eisen

    Cedars-Sinai Heart Institute, CA; University of Florida College of Medicine, FL; Toronto General Hospital, Toronto, Canada; Intermountain Medical Center, UT; Medical University of South Carolina, SC; Novartis Pharmaceuticals Corp, NJ; Novartis Pharma AG, Basel, Switzerland; Cleveland Clinic, OH; Drexel University College of Medicine, PA

    Purpose: 24-month (M) results of a randomized, open-label, multinational study (A2310) comparing efficacy and safety of everolimus (EVR) and mycophenolate mofetil (MMF) in de novo…
  • 2013 American Transplant Congress

    Most Late Kidney Graft Failures after Simultaneous Kidney-Pancreas Transplant (SPK) Are Due to Non-Immunological Graft Injury

    Z. Stewart, L. Hunsicker

    Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA; Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA

    Background: Late allograft failure is one of the critical issues in renal transplantation today. The relative importance of immunological versus non-immunological causes of chronic kidney…
  • 2013 American Transplant Congress

    Comparison of Hepatitis C Recurrence in Orthotopic Liver Transplant Recipients Receiving Antibody Induction Versus No Antibody Induction

    S. Patel, P. West-Thielke, H. Jeon, E. Benedetti, J. Thielke

    Pharmacy Practice, University of Illinois Hospital and Health Sciences System, Chicago, IL; Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL

    Purpose: Compare the incidence of hepatitis C virus (HCV) recurrence in orthotopic liver transplant (OLT) recipients receiving induction to subjects that were transplanted without induction…
  • 2013 American Transplant Congress

    Endodermal Precursor Cells Derived from Embryonic Stem Cells Can Engraft in Mouse Liver

    N. Liu, J. Fair

    Surgery, University of Florida, Gainesville, FL

    Purpose: Embryonic stem (ES) cells have been shown to have great value therapeutically due to their limitless capacity for self-renewal and proliferation, and their ability…
  • 2013 American Transplant Congress

    Development of De Novo Anti-HLA Antibodies after Treatment with/without Rituximab, a B Cell−Depleting Treatment

    Y. Sawada, H. Ishida, K. Omoto, T. Nozaki, T. Shimizu, M. Inui, K. Tanabe

    Urology, 8-1 Kawada-Cho, Shinjuku-ku, Tokyo, Japan

    Background: Organ shortages have forced a widening of the indications for kidney donors. In Japan, ABO-incompatible kidney transplantation (ABOi) is a popular alternative to deceased…
  • 2013 American Transplant Congress

    Monoclonal Antibody Which Possibly May Replace the Therapeutic Intravenous Immunoglobulin, A

    M. Ravindranath, P. Terasaki

    HLA Antibodies, Terasaki Foundation Laboratory, Los Angeles, CA

    The value of intravenous immunoglobulin (IVIg) in lowering HLA antibodies (Abs) has recently come into question. High variability in different therapeutic preparations may account for…
  • 2013 American Transplant Congress

    Prevalence of Human Papillomavirus (HPV) Infection in Female Kidney Transplant Recipients

    J. Mayorga, M. Jiménez-Santana, R. Barrón, R. Gamboa-Martínez, J. Sifuentes-Osornio, M. Cravioto, J. Alberu

    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF, Mexico

    Introduction: Kidney transplant recipients are at higher risk for viral infection-related cancers. Even though HPV infection is strongly associated with several genital cancers, data on…
  • 2013 American Transplant Congress

    Tacrolimus Concentration Variability Is Associated with Delayed Graft Function and Diminished Renal Function in Kidney Transplant Recipients

    C. Makowski, N. Pilch, H. Meadows, C. Bratton, J. McGillicuddy, K. Chavin, P. Baliga, D. Taber

    Pharmacy, MUSC, Charleston, SC; Surgery, MUSC, Charleston, SC

    Background: Tacrolimus (FK) is the drug of choice for preventing acute allograft rejection in kidney transplantation. However, therapeutic drug monitoring is necessary due to FK’s…
  • 2013 American Transplant Congress

    Pretransplant CD8+CD28-NKG2D+ Memory T Cells and Third Party Cellular Alloreactivity as a Predictor of Posttransplant Acute Cellular Rejection

    O. Traitanon, J. Augustine, R. Fairchild, E. Poggio

    Nephrology & Hypertension, Cleveland Clinic, Cleveland, OH; Renal Division, Univ Hospitals of Cleveland, Cleveland, OH; Immunology, Cleveland Clinic, Cleveland, OH

    Background: Cellular alloreactivity is prevalent in patients prior to transplantation. A previous retrospective study showed that high cellular alloreactivity to a panel of third party…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences